Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01413243 (ClinicalTrials.gov)	September 2012	8/8/2011	Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome	Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome - A Monocentric, Prospective, Randomized, Double-blind and Placebo-controlled Phase 2 Trial	Multiple Sclerosis	Drug: Trichuris suis ova	Charite University, Berlin, Germany	NULL	Terminated	18 Years	65 Years	Both	50	Phase 2	Germany
2	EUCTR2009-015319-41-DE (EUCTR)	03/11/2011	04/02/2011	Trichuris suis Oozyten (TSO®) in remittent-recurrent Multiple Sclerosis (MS) and Clinically Isolated Syndrom (CIS)	Trichuris suis Oozyten (TSO®) in remittent-recurrent Multiple Sclerosis (MS) and Clinically Isolated Syndrom (CIS) - TRIOMS	remittent-recurrent Multiple Sclerosis (MS) and Clinically Isolated Syndrom (CIS);Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]	Product Name: TSO Product Code: TSO INN or Proposed INN: Trichuris suis ova (eggs), embryonated, viable	Charite Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 2	Germany
3	NCT01006941 (ClinicalTrials.gov)	May 2010	7/10/2009	Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study	Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study	Relapsing Multiple Sclerosis	Biological: Trichuris suis ova	Rigshospitalet, Denmark	University of Copenhagen;Statens Serum Institut;Copenhagen University Hospital, Hvidovre;OvaMed GmbH	Completed	19 Years	55 Years	Both	10	Phase 2	Denmark
4	EUCTR2008-007549-29-DK (EUCTR)	09/06/2009	06/05/2009	Trichuris suis Ova Therapy for Relapsing Multiple Sclerosis - a safety study - TRIMS A	Trichuris suis Ova Therapy for Relapsing Multiple Sclerosis - a safety study - TRIMS A	Relapsing Multipel Sclerosis MedDRA version: 12.0;Level: LLT;Classification code 10028245;Term: Multiple sclerosis MedDRA version: 12.0;Classification code 10063399;Term: Relapsing-remitting multiple sclerosis MedDRA version: 12.0;Classification code 10053395;Term: Progressive multiple sclerosis	Product Name: Trichuris suis Ova Product Code: TSO INN or Proposed INN: Trichuris suis eggs Other descriptive name: Trichuris suis eggs	Danish Multiple Sclerosis Research Center	NULL	Not Recruiting			Female: yes Male: yes	10	Phase 2	Denmark